Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

Self-Assessment of Vocal Fatigue in Muscle Tension Dysphonia and Vocal Nodules: A Preliminary Analysis of the Discriminatory Potential of the Croatian Adaptation of the Vocal Fatigue Index (VFI-C).

Bonetti A, Bonetti L, Čipčić O.

J Voice. 2019 Oct 9. pii: S0892-1997(19)30222-X. doi: 10.1016/j.jvoice.2019.08.028. [Epub ahead of print]

PMID:
31606223
2.

Characterization of Bifidobacterium species in feaces of the Egyptian fruit bat: Description of B. vespertilionis sp. nov. and B. rousetti sp. nov.

Modesto M, Satti M, Watanabe K, Puglisi E, Morelli L, Huang CH, Liou JS, Miyashita M, Tamura T, Saito S, Mori K, Huang L, Sciavilla P, Sandri C, Spiezio C, Vitali F, Cavalieri D, Perpetuini G, Tofalo R, Bonetti A, Arita M, Mattarelli P.

Syst Appl Microbiol. 2019 Nov;42(6):126017. doi: 10.1016/j.syapm.2019.126017. Epub 2019 Sep 23.

PMID:
31585749
3.

Immune-checkpoint inhibitors in head and neck squamous cell carcinoma: cost-efficacy in second-line treatment based on programmed death-ligand 1 (PD-L1) level.

Giuliani J, Bonetti A.

Oral Oncol. 2019 Oct;97:143-145. doi: 10.1016/j.oraloncology.2019.08.010. Epub 2019 Aug 17. No abstract available.

PMID:
31431352
4.

The exposure to perfluoroalkyl substances (PFAS) and the development of cancer.

Giuliani J, Bonetti A.

Recenti Prog Med. 2019 Jul-Aug;110(7):368-370. doi: 10.1701/3197.31750. Italian. No abstract available.

PMID:
31379373
5.

Netupitant plus palonosetron is a cost-effective treatment for the prophylaxis of chemotherapy-induced nausea and vomiting in highly and moderately emetogenic cancer treatment.

Giuliani J, Bonetti A.

Expert Rev Pharmacoecon Outcomes Res. 2019 Oct;19(5):505-508. doi: 10.1080/14737167.2019.1650644. Epub 2019 Aug 4.

PMID:
31379219
6.

Assessment of the genotoxic potential of water courses impacted by wastewater treatment effluents using micronucleus assay in plants from the species Tradescantia.

Campos CF, Morelli S, De Campos Júnior EO, Santos VSV, De Morais CR, Cunha MC, Souto HN, Pavanin LA, Bonetti AM, Pereira BB.

J Toxicol Environ Health A. 2019;82(13):752-759. doi: 10.1080/15287394.2019.1648345. Epub 2019 Jul 31.

PMID:
31362592
7.
8.

The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab.

Giuliani J, Bonetti A.

Anticancer Res. 2019 Jul;39(7):3971-3973. doi: 10.21873/anticanres.13552.

PMID:
31262930
9.
10.

Financial Toxicity and Non-small Cell Lung Cancer Treatment: The Optimization in the Choice of Immune Check Point Inhibitors.

Giuliani J, Bonetti A.

Anticancer Res. 2019 Jul;39(7):3961-3965. doi: 10.21873/anticanres.13550. Review.

PMID:
31262928
11.

Economic sustainability of nivolumab at flat dose for second-line treatment of metastatic non-small cell lung cancer in real life.

Giuliani J, Albanese V, Ponturo G, Bonetti A.

J Oncol Pharm Pract. 2019 Dec;25(8):2059-2060. doi: 10.1177/1078155219854125. Epub 2019 Jun 10. No abstract available.

PMID:
31181991
12.

Genotoxicity and carcinogenicity of ivermectin and amoxicillin in vivo systems.

de Sousa FA, de Morais CR, Vieira JS, Maranho LS, Machado FL, Pereira S, Barbosa LC, Coelho HE, Campos CF, Bonetti AM.

Environ Toxicol Pharmacol. 2019 Aug;70:103196. doi: 10.1016/j.etap.2019.103196. Epub 2019 May 23.

PMID:
31152944
13.

Evaluation of the genotoxicity of neurotoxic insecticides using the micronucleus test in Tradescantia pallida.

de Morais CR, Pereira BB, Almeida Sousa PC, Vieira Santos VS, Campos CF, Carvalho SM, Spanó MA, de Rezende AAA, Bonetti AM.

Chemosphere. 2019 Jul;227:371-380. doi: 10.1016/j.chemosphere.2019.04.073. Epub 2019 Apr 12.

PMID:
30999177
14.

Immunotherapy in first-line for advanced non-small cell lung cancer: <br>a cost-effective choice?

Giuliani J, Bonetti A.

Recenti Prog Med. 2019 Mar;110(3):138-143. doi: 10.1701/3132.31141.

PMID:
30968854
15.

Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions.

Tonin FS, Lopes LA, Rotta I, Bonetti AF, Pontarolo R, Correr CJ, Fernandez-Llimos F.

Int J Clin Pharm. 2019 Jun;41(3):785-792. doi: 10.1007/s11096-019-00818-2. Epub 2019 Apr 9.

PMID:
30963446
16.

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.

Di Bartolomeo M, Niger M, Morano F, Corallo S, Antista M, Tamberi S, Lonardi S, Di Donato S, Berardi R, Scartozzi M, Cardellino GG, Di Costanzo F, Rimassa L, Luporini AG, Longarini R, Zaniboni A, Bertolini A, Tomasello G, Pinotti G, Scagliotti G, Tortora G, Bonetti A, Spallanzani A, Frassineti GL, Tassinari D, Giuliani F, Cinieri S, Maiello E, Verusio C, Bracarda S, Catalano V, Basso M, Ciuffreda L, De Vita F, Parra HS, Fornaro L, Caporale M, de Braud F, Pietrantonio F.

BMC Cancer. 2019 Mar 29;19(1):283. doi: 10.1186/s12885-019-5498-3.

17.

Impact of Pharmacist-led Discharge Counseling on Hospital Readmission and Emergency Department Visits: A Systematic Review and Meta-analysis.

Bonetti AF, Reis WC, Mendes AM, Rotta I, Tonin FS, Fernandez-Llimos F, Pontarolo R.

J Hosp Med. 2019 Mar 20;14:E1-E8. doi: 10.12788/jhm.3182. [Epub ahead of print] Review.

PMID:
30897055
18.
19.

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).

Pasello G, Vicario G, Zustovich F, Oniga F, Gori S, Rosetti F, Bonetti A, Favaretto A, Toso S, Redelotti R, Santo A, Bernardi D, Giovanis P, Oliani C, Calvetti L, Gatti C, Palazzolo G, Baretta Z, Bortolami A, Bonanno L, Basso M, Menis J, Corte DD, Frega S, Guarneri V, Conte P; Veneto Oncology Network.

Oncologist. 2019 Jun;24(6):e318-e326. doi: 10.1634/theoncologist.2018-0712. Epub 2019 Mar 7.

PMID:
30846513
20.

Affordable Production of Antioxidant Aqueous Solutions by Hydrodynamic Cavitation Processing of Silver Fir (Abies alba Mill.) Needles.

Albanese L, Bonetti A, D'Acqui LP, Meneguzzo F, Zabini F.

Foods. 2019 Feb 12;8(2). pii: E65. doi: 10.3390/foods8020065.

21.

Genotoxic and mutagenic assessment of spinosad using bioassays with Tradescantia pallida and Drosophila melanogaster.

Mendonça TP, Davi de Aquino J, Junio da Silva W, Mendes DR, Campos CF, Vieira JS, Barbosa NP, Carvalho Naves MP, Olegário de Campos Júnior E, Alves de Rezende AA, Spanó MA, Bonetti AM, Vieira Santos VS, Pereira BB, Resende de Morais C.

Chemosphere. 2019 May;222:503-510. doi: 10.1016/j.chemosphere.2019.01.182. Epub 2019 Jan 31.

PMID:
30721808
22.

Brain-enriched MicroRNA-184 is downregulated in older adults with major depressive disorder: A translational study.

Mendes-Silva AP, Fujimura PT, Silva JRDC, Teixeira AL, Vieira EM, Guedes PHG, Barroso LSS, Nicolau MS, Ferreira JDR, Bertola L, Nicolau ES, Tolentino-Araújo GT, Berlezzi CMSF, Rodrigues TS, Borges LDF, Gomes MS, Amaral LRD, Bonetti AM, Ueira-Vieira C, Diniz BS.

J Psychiatr Res. 2019 Apr;111:110-120. doi: 10.1016/j.jpsychires.2019.01.019. Epub 2019 Jan 23.

PMID:
30716647
23.

FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer.

Giuliani J, Bonetti A.

Pancreatology. 2019 Mar;19(2):325-330. doi: 10.1016/j.pan.2019.01.014. Epub 2019 Jan 19.

PMID:
30704852
24.

Mutagenic and genotoxic effects induced by PM0.5 of different Italian towns in human cells and bacteria: The MAPEC_LIFE study.

Bonetta S, Bonetta S, Schilirò T, Ceretti E, Feretti D, Covolo L, Vannini S, Villarini M, Moretti M, Verani M, Carducci A, Bagordo F, De Donno A, Bonizzoni S, Bonetti A, Pignata C, Carraro E, Gelatti U; MAPEC_LIFE Study Group.

Environ Pollut. 2019 Feb;245:1124-1135. doi: 10.1016/j.envpol.2018.11.017. Epub 2018 Nov 10.

PMID:
30682747
25.

Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report.

Parcesepe P, Giordano G, Zanella C, Giuliani J, Greco F, Bonetti A, Pancione M, Manfrin E, Molinari E, Latiano TP, D'Andrea MR, Fassan M, Olivieri N, Remo A.

Pathol Res Pract. 2019 Feb;215(2):387-391. doi: 10.1016/j.prp.2018.11.021. Epub 2018 Nov 29.

PMID:
30553605
26.

Cost-Effectiveness of Second-Line Treatments for Metastatic Renal-Cell Carcinoma.

Giuliani J, Bonetti A.

Clin Genitourin Cancer. 2019 Apr;17(2):e258-e262. doi: 10.1016/j.clgc.2018.11.010. Epub 2018 Nov 22.

PMID:
30545674
27.

Which grade is of clinical benefit in the randomised controlled trials? The example of 54th American Society of Clinical Oncology annual meeting, 2018.

Giuliani J, Bonetti A.

Eur J Cancer. 2018 Nov;104:233-235. doi: 10.1016/j.ejca.2018.08.026. Epub 2018 Oct 11. No abstract available.

PMID:
30318320
28.

First-line therapies in metastatic colorectal cancer: integrating clinical benefit with the costs of drugs.

Giuliani J, Bonetti A.

Int J Colorectal Dis. 2018 Nov;33(11):1505-1516. doi: 10.1007/s00384-018-3158-8. Epub 2018 Sep 8. Review.

PMID:
30196427
29.

Bifidobacterium primatium sp. nov., Bifidobacterium scaligerum sp. nov., Bifidobacterium felsineum sp. nov. and Bifidobacterium simiarum sp. nov.: Four novel taxa isolated from the faeces of the cotton top tamarin (Saguinus oedipus) and the emperor tamarin (Saguinus imperator).

Modesto M, Puglisi E, Bonetti A, Michelini S, Spiezio C, Sandri C, Sgorbati B, Morelli L, Mattarelli P.

Syst Appl Microbiol. 2018 Nov;41(6):593-603. doi: 10.1016/j.syapm.2018.07.005. Epub 2018 Aug 23.

PMID:
30150092
30.

Health Risk Associated with Exposure to PM10 and Benzene in Three Italian Towns.

De Donno A, De Giorgi M, Bagordo F, Grassi T, Idolo A, Serio F, Ceretti E, Feretti D, Villarini M, Moretti M, Carducci A, Verani M, Bonetta S, Pignata C, Bonizzoni S, Bonetti A, Gelatti U; MAPEC_LIFE Study Group.

Int J Environ Res Public Health. 2018 Aug 6;15(8). pii: E1672. doi: 10.3390/ijerph15081672.

31.

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer.

Borelli B, Moretto R, Lonardi S, Bonetti A, Antoniotti C, Pietrantonio F, Masi G, Burgio V, Marmorino F, Salvatore L, Rossini D, Zaniboni A, Zucchelli G, Martignetti A, Di Battista M, Pella N, Passardi A, Boccaccino A, Leone F, Colombo C, Granetto C, Vannini F, Marsico VA, Martinelli E, Antonuzzo L, Vitello S, Delliponti L, Boni L, Cremolini C, Falcone A.

ESMO Open. 2018 Jul 9;3(4):e000403. doi: 10.1136/esmoopen-2018-000403. eCollection 2018.

32.

Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis.

Lucchetta RC, Tonin FS, Borba HHL, Leonart LP, Ferreira VL, Bonetti AF, Riveros BS, Becker J, Pontarolo R, Fernandez-Llimós F, Wiens A.

CNS Drugs. 2018 Sep;32(9):813-826. doi: 10.1007/s40263-018-0541-5. Review.

PMID:
30014314
33.

Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.

Vitale MG, Scagliarini S, Galli L, Pignata S, Lo Re G, Berruti A, Defferrari C, Spada M, Masini C, Santini D, Ciuffreda L, Ruggeri EM, Bengala C, Livi L, Fagnani D, Bonetti A, Giustini L, Hamzaj A, Procopio G, Caserta C, Sabbatini R.

PLoS One. 2018 Jul 6;13(7):e0199642. doi: 10.1371/journal.pone.0199642. eCollection 2018.

34.

Long-term survival in advanced pancreatic cancer.

Giuliani J, Bonetti A.

Recenti Prog Med. 2018 Jun;109(6):352-358. doi: 10.1701/2932.29492. No abstract available.

PMID:
29968866
35.

Buccal micronucleus cytome assay in primary school children: A descriptive analysis of the MAPEC_LIFE multicenter cohort study.

Villarini M, Levorato S, Salvatori T, Ceretti E, Bonetta S, Carducci A, Grassi T, Vannini S, Donato F, Bonetta S, Verani M, de Donno A, Bonizzoni S, Bonetti A, Moretti M, Gelatti U; MAPEC LIFE Study Group.

Int J Hyg Environ Health. 2018 Jul;221(6):883-892. doi: 10.1016/j.ijheh.2018.05.014. Epub 2018 Jun 18.

PMID:
29914775
36.

Anti-angiogenic agents in second-line treatment for metastatic colorectal cancer: the optimization of pharmacological costs.

Giuliani J, Bonetti A.

Int J Colorectal Dis. 2018 Oct;33(10):1487-1491. doi: 10.1007/s00384-018-3077-8. Epub 2018 May 26.

PMID:
29804191
37.

Ecotoxicological effects of the insecticide fipronil in Brazilian native stingless bees Melipona scutellaris (Apidae: Meliponini).

de Morais CR, Travençolo BAN, Carvalho SM, Beletti ME, Vieira Santos VS, Campos CF, de Campos Júnior EO, Pereira BB, Carvalho Naves MP, de Rezende AAA, Spanó MA, Vieira CU, Bonetti AM.

Chemosphere. 2018 Sep;206:632-642. doi: 10.1016/j.chemosphere.2018.04.153. Epub 2018 May 10.

PMID:
29778941
38.

Impact of discharge medication counseling in the cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial.

Bonetti AF, Bagatim BQ, Mendes AM, Rotta I, Reis RC, Fávero MLD, Fernandez-Llimós F, Pontarolo R.

Clinics (Sao Paulo). 2018;73:e325. doi: 10.6061/clinics/2018/e325. Epub 2018 Apr 26.

39.

Pharmacist-led discharge medication counselling: A scoping review.

Bonetti AF, Reis WC, Lombardi NF, Mendes AM, Netto HP, Rotta I, Fernandez-Llimos F, Pontarolo R.

J Eval Clin Pract. 2018 Jun;24(3):570-579. doi: 10.1111/jep.12933. Epub 2018 Apr 24. Review.

PMID:
29691955
40.

Regorafenib or Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer? A Perspective on the Basis of Pharmacological Costs.

Giuliani J, Bonetti A.

Clin Colorectal Cancer. 2018 Jun;17(2):e381-e383. doi: 10.1016/j.clcc.2018.02.009. Epub 2018 Feb 23. No abstract available.

PMID:
29550155
41.

Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma.

Giuliani J, Bonetti A.

Clin Genitourin Cancer. 2018 Jun;16(3):e557-e562. doi: 10.1016/j.clgc.2018.02.006. Epub 2018 Feb 22.

PMID:
29534940
42.

Evaluation of toxicity, mutagenicity and carcinogenicity of samples from domestic and industrial sewage.

Resende de Morais C, Bonetti AM, Mota AA, Campos CF, Souto HN, Carvalho Naves MP, Vieira Santos VS, Olegário de Campos Júnior E, Pavanin LA, Alves de Rezende AA, Spanó MA, Pereira BB.

Chemosphere. 2018 Jun;201:342-350. doi: 10.1016/j.chemosphere.2018.03.016. Epub 2018 Mar 3.

PMID:
29525663
43.

Haematemesis related to orthodontic treatment with Nance palatal arch: a case report.

Patini R, Bonetti AA, Camodeca A, Staderini E, Gallenzi P.

J Orthod. 2018 Jun;45(2):125-128. doi: 10.1080/14653125.2018.1445505. Epub 2018 Mar 7.

PMID:
29513094
44.

Draft Genome Sequences of Strains TRE 1, TRE D, TRE H, and TRI 7, Isolated from Tamarins and Belonging to Four Putative Novel Bifidobacterium Species.

Puglisi E, Mattarelli P, Modesto M, Bonetti A, Spiezio C, Sandri C, Morelli L.

Genome Announc. 2018 Jan 18;6(3). pii: e01449-17. doi: 10.1128/genomeA.01449-17.

45.

Impact on process results of clinical decision support systems (CDSSs) applied to medication use: overview of systematic reviews.

Reis WC, Bonetti AF, Bottacin WE, Reis AS Jr, Souza TT, Pontarolo R, Correr CJ, Fernandez-Llimos F.

Pharm Pract (Granada). 2017 Oct-Dec;15(4):1036. doi: 10.18549/PharmPract.2017.04.1036. Epub 2017 Dec 18.

46.
47.

Birth, coming of age and death: The intriguing life of long noncoding RNAs.

Samudyata, Castelo-Branco G, Bonetti A.

Semin Cell Dev Biol. 2018 Jul;79:143-152. doi: 10.1016/j.semcdb.2017.11.012. Epub 2017 Nov 20. Review.

PMID:
29133230
49.

Unexpectedly high genetic diversity and divergence among populations of the apomictic Neotropical tree Miconia albicans.

Dias ACC, Serra AC, Sampaio DS, Borba EL, Bonetti AM, Oliveira PE.

Plant Biol (Stuttg). 2018 Mar;20(2):244-251. doi: 10.1111/plb.12654. Epub 2017 Nov 28.

PMID:
29069536
50.

The Pharmacological Costs of Second-Line Treatments for Recurrent Ovarian Cancer.

Giuliani J, Bonetti A.

Int J Gynecol Cancer. 2017 Nov;27(9):1872-1876. doi: 10.1097/IGC.0000000000001106.

PMID:
28976446

Supplemental Content

Loading ...
Support Center